SI2236598T1 - Mikroorganizmi za izboljšanje zdravja posameznikov z motnjami, ki se nanašajo na uživanje glutena - Google Patents
Mikroorganizmi za izboljšanje zdravja posameznikov z motnjami, ki se nanašajo na uživanje glutenaInfo
- Publication number
- SI2236598T1 SI2236598T1 SI200830918T SI200830918T SI2236598T1 SI 2236598 T1 SI2236598 T1 SI 2236598T1 SI 200830918 T SI200830918 T SI 200830918T SI 200830918 T SI200830918 T SI 200830918T SI 2236598 T1 SI2236598 T1 SI 2236598T1
- Authority
- SI
- Slovenia
- Prior art keywords
- microorganisms
- individuals
- health
- improving
- disorders related
- Prior art date
Links
- 108010068370 Glutens Proteins 0.000 title 1
- 230000037406 food intake Effects 0.000 title 1
- 235000021312 gluten Nutrition 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200703427A ES2343499B1 (es) | 2007-12-24 | 2007-12-24 | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten. |
EP08865212A EP2236598B1 (en) | 2007-12-24 | 2008-12-23 | Microorganisms for improving the health of individuals with disorders related to gluten ingestion |
PCT/ES2008/070243 WO2009080862A1 (es) | 2007-12-24 | 2008-12-23 | Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2236598T1 true SI2236598T1 (sl) | 2013-08-30 |
Family
ID=40800750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200830918T SI2236598T1 (sl) | 2007-12-24 | 2008-12-23 | Mikroorganizmi za izboljšanje zdravja posameznikov z motnjami, ki se nanašajo na uživanje glutena |
Country Status (16)
Country | Link |
---|---|
US (1) | US8501169B2 (sl) |
EP (1) | EP2236598B1 (sl) |
JP (1) | JP5693232B2 (sl) |
KR (1) | KR20100110341A (sl) |
CN (1) | CN101983237B (sl) |
AU (1) | AU2008341708B2 (sl) |
BR (1) | BRPI0819533B1 (sl) |
CA (1) | CA2710666C (sl) |
CY (1) | CY1113848T1 (sl) |
DK (1) | DK2236598T3 (sl) |
ES (2) | ES2343499B1 (sl) |
MX (1) | MX2010007038A (sl) |
PL (1) | PL2236598T3 (sl) |
PT (1) | PT2236598E (sl) |
SI (1) | SI2236598T1 (sl) |
WO (1) | WO2009080862A1 (sl) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110081320A1 (en) * | 2009-10-06 | 2011-04-07 | Nubiome, Inc. | Treatment/Cure of Autoimmune Disease |
US20140187474A1 (en) * | 2011-02-16 | 2014-07-03 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic use of mucin glycans |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
CN108771687A (zh) * | 2012-02-29 | 2018-11-09 | 伊西康内外科公司 | 微生物区系的组合物及与其相关的方法 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
FI127483B (en) | 2014-06-11 | 2018-07-13 | Gut Guide Oy | Microbial marker for celiac disease and related product |
CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
WO2016080448A1 (ja) | 2014-11-19 | 2016-05-26 | 株式会社ヤクルト本社 | セリアック病予防治療剤 |
HUE037476T2 (hu) | 2014-12-23 | 2018-08-28 | 4D Pharma Res Ltd | Pirin polipeptid és immunmodulálás |
LT3065748T (lt) | 2014-12-23 | 2018-03-12 | 4D Pharma Research Limited | Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui |
ES2575828B1 (es) | 2014-12-31 | 2017-07-07 | Universidad De León | Empleo de probióticos en el incremento de la fertilidad masculina |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3636272A1 (en) | 2015-06-15 | 2020-04-15 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
LT3650033T (lt) | 2015-06-15 | 2022-04-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterinius kamienus |
RS59308B1 (sr) | 2015-06-15 | 2019-10-31 | 4D Pharma Res Ltd | Kompozicije koje sadrže bakterijske sojeve |
GB201515557D0 (en) * | 2015-09-02 | 2015-10-14 | 14M Genomics Ltd | Method of sequencing |
GB2561748B (en) | 2015-11-20 | 2019-05-08 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
TW201733601A (zh) | 2016-03-04 | 2017-10-01 | 4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
EP3222282A1 (en) * | 2016-03-21 | 2017-09-27 | Bionou Research, S.L. | Use of probiotics in the treatment and/or prevention of psoriasis |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
EP3272396A1 (en) * | 2016-07-18 | 2018-01-24 | Bionou Research, S.L. | Use of probiotics in the treatment and/or prevention of atopic dermatitis |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
EP3554520A4 (en) * | 2016-12-16 | 2020-09-30 | Vedanta Biosciences, Inc. | METHODS AND COMPOSITIONS FOR DETERMINING BACTERIAL INTEGRITY |
MA48940A (fr) | 2017-05-22 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3630942B1 (en) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
MD3638271T2 (ro) | 2017-06-14 | 2021-03-31 | 4D Pharma Res Ltd | Compoziții cuprizând tulpini bacteriene |
DK3804737T3 (da) | 2017-06-14 | 2022-07-25 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
BR112020010929A2 (pt) | 2017-12-29 | 2020-11-17 | Société des Produits Nestlé S.A. | produção de serpina |
WO2020069282A1 (en) * | 2018-09-27 | 2020-04-02 | Research Development Foundation | Methods and probiotic compositions for the treatment of bone disorders |
WO2020160680A1 (en) * | 2019-02-08 | 2020-08-13 | Mcmaster University | Use of activators of the aryl hydrocarbon receptor for treating gluten-induced gastrointestinal diseases. |
CN114845571A (zh) | 2019-12-23 | 2022-08-02 | 赢创运营有限公司 | 用于麸质降解的包含至少一种芽孢杆菌属和乳杆菌属菌株的细菌聚生体 |
CN112694992B (zh) * | 2020-12-30 | 2023-02-21 | 江南大学 | 一株可缓解腹泻的两歧双歧杆菌及其应用 |
CN115400154A (zh) * | 2022-08-10 | 2022-11-29 | 深圳未知君生物科技有限公司 | 长双歧杆菌在制备治疗自闭症谱系障碍的药物中的应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7285526B2 (en) | 1995-07-14 | 2007-10-23 | Meiogen Biotechnology Corporation | Interferon antagonists useful for the treatment of interferon related diseases |
ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
US6562943B1 (en) | 1999-04-21 | 2003-05-13 | Zycos, Inc. | Peptide epitopes recognized by disease promoting CD4+ T lymphocytes |
US20030092163A1 (en) * | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
US7320788B2 (en) | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
ITMI20020399A1 (it) * | 2002-02-28 | 2003-08-28 | Ct Sperimentale Del Latte S P | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici |
US7202216B2 (en) | 2002-05-14 | 2007-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
GB0323039D0 (en) * | 2003-10-01 | 2003-11-05 | Danisco | Method |
US7579313B2 (en) | 2003-11-18 | 2009-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
US7563864B2 (en) | 2004-04-26 | 2009-07-21 | Celiac Sprue Research Foundation | Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten |
WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
US8071101B2 (en) | 2005-11-03 | 2011-12-06 | Avaxia Biologics, Inc. | Antibody therapy for treatment of diseases associated with gluten intolerance |
CA2838399C (en) | 2006-02-09 | 2017-03-07 | Alba Therapeutics Corporation | Formulations for a tight junction effector |
WO2007108763A1 (en) | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
-
2007
- 2007-12-24 ES ES200703427A patent/ES2343499B1/es active Active
-
2008
- 2008-12-23 KR KR1020107016396A patent/KR20100110341A/ko not_active Application Discontinuation
- 2008-12-23 JP JP2010540149A patent/JP5693232B2/ja active Active
- 2008-12-23 CN CN2008801274139A patent/CN101983237B/zh active Active
- 2008-12-23 SI SI200830918T patent/SI2236598T1/sl unknown
- 2008-12-23 AU AU2008341708A patent/AU2008341708B2/en active Active
- 2008-12-23 PT PT88652128T patent/PT2236598E/pt unknown
- 2008-12-23 PL PL08865212T patent/PL2236598T3/pl unknown
- 2008-12-23 WO PCT/ES2008/070243 patent/WO2009080862A1/es active Application Filing
- 2008-12-23 ES ES08865212T patent/ES2402183T3/es active Active
- 2008-12-23 MX MX2010007038A patent/MX2010007038A/es active IP Right Grant
- 2008-12-23 CA CA2710666A patent/CA2710666C/en active Active
- 2008-12-23 EP EP08865212A patent/EP2236598B1/en active Active
- 2008-12-23 US US12/810,369 patent/US8501169B2/en active Active
- 2008-12-23 DK DK08865212.8T patent/DK2236598T3/da active
- 2008-12-23 BR BRPI0819533-1A patent/BRPI0819533B1/pt active IP Right Grant
-
2013
- 2013-03-26 CY CY20131100250T patent/CY1113848T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL2236598T3 (pl) | 2013-08-30 |
EP2236598B1 (en) | 2012-12-26 |
CN101983237B (zh) | 2013-06-12 |
CA2710666A1 (en) | 2009-07-02 |
JP2011507540A (ja) | 2011-03-10 |
MX2010007038A (es) | 2010-10-15 |
CY1113848T1 (el) | 2016-07-27 |
ES2343499A1 (es) | 2010-08-02 |
ES2343499B1 (es) | 2011-06-10 |
BRPI0819533A2 (pt) | 2014-10-14 |
CA2710666C (en) | 2018-12-04 |
ES2402183T3 (es) | 2013-04-29 |
US8501169B2 (en) | 2013-08-06 |
BRPI0819533B1 (pt) | 2018-06-05 |
KR20100110341A (ko) | 2010-10-12 |
PT2236598E (pt) | 2013-04-02 |
JP5693232B2 (ja) | 2015-04-01 |
DK2236598T3 (da) | 2013-04-02 |
AU2008341708A1 (en) | 2009-07-02 |
CN101983237A (zh) | 2011-03-02 |
AU2008341708B2 (en) | 2014-07-17 |
EP2236598A4 (en) | 2012-01-25 |
WO2009080862A1 (es) | 2009-07-02 |
EP2236598A1 (en) | 2010-10-06 |
US20100310520A1 (en) | 2010-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2236598T3 (pl) | Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu | |
ZA201000246B (en) | Improvements relating to the fitting of spectacles | |
HK1202441A1 (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
PL2318035T3 (pl) | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego | |
HK1129426A1 (zh) | 用於治療肺部病症的酶的合成物 | |
IL195906A0 (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
AU2008233088A8 (en) | Calcimimetic compounds for use in the treatment of bowel disorders | |
EP2356991A4 (en) | USE OF BACTERIA OF THE GENUS TENACIBACULUM TO OBTAIN QUORUM QUENCHING | |
ZA201108106B (en) | Use of phthalimide derivatives in the treatment of diseases | |
ZA201005875B (en) | Use of interleukin-1 conjugates in the treatment of diabetes | |
EP2225559B8 (en) | Assessment of physiological conditions | |
GB0902537D0 (en) | Improvememts in or relating to the creation of curved forms | |
GB0720400D0 (en) | Improvements in or relating to the preparation of beverages | |
GB0902538D0 (en) | Improvvements in or relating to the creation of curved forms | |
IL206128A0 (en) | Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders | |
HK1145282A1 (en) | Treatment of sleep disorders | |
GB2432276B (en) | Connecting to the internet | |
PL379557A1 (pl) | Sposób otrzymywania preparatu enzymów | |
PL379558A1 (pl) | Sposób otrzymywania preparatu enzymów | |
AU2008904643A0 (en) | Joint and arthritis health formula | |
GB0711369D0 (en) | Improvements to the measurement of daily activity | |
GB0720032D0 (en) | Improvements relating to the entrapment of fine particulates | |
AU2007900485A0 (en) | Indentifying Persons Susceptible to Pathological Myopia | |
AU2008903823A0 (en) | Health Supplement Compositions | |
AU2007901448A0 (en) | Improvements to Cannulation |